The authors present a case study in which a patient being treated with clozapine was found dead with toxic levels of the drug in her blood. While the coroner expressed concern over the possibility of suicide, the authors argue that the elevated drug concentrations might instead have been caused by a postmortem redistribution of clozapine in the patient’s system, which has previously been described in other triciyclic antidepressants, though never clozapine. (3 refs)